TSCAN THERAPEUTICS INC

Ticker: TCRX CUSIP: 89854M101 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 115,400 Value ($000) $115 Avg Close $1.45 Range $0.88 - $2.57
Q3 2025
Shares 140,400 Value ($000) $256 Avg Close $1.77 Range $1.43 - $1.99
Q2 2025
Shares 153,700 Value ($000) $223 Avg Close $1.44 Range $1.02 - $1.87
Q1 2025
Shares 113,300 Value ($000) $156 Avg Close $2.16 Range $1.28 - $3.21
Q4 2024
Shares 105,900 Value ($000) $322 Avg Close $4.53 Range $2.60 - $6.22
Q3 2024
Shares 38,300 Value ($000) $191 Avg Close $6.03 Range $4.90 - $7.89
Q2 2024
Shares 38,300 Value ($000) $224 Avg Close $7.88 Range $5.60 - $9.69
Q1 2024
Shares 63,300 Value ($000) $503 Avg Close $6.29 Range $4.64 - $9.00
Q4 2023
Shares 88,300 Value ($000) $515 Avg Close $4.58 Range $2.43 - $7.15
Q3 2023
Shares 88,300 Value ($000) $226 Avg Close $2.33 Range $1.93 - $3.04
Q2 2023
Shares 50,000 Value ($000) $125 Avg Close $2.68 Range $1.62 - $6.03
Q1 2023
Shares 115,000 Value ($000) $242 Avg Close $2.37 Range $1.60 - $3.40
Q4 2022
Shares 115,000 Value ($000) $187 Avg Close $2.45 Range $1.45 - $3.65
Q3 2022
Shares 115,000 Value ($000) $351 Avg Close $3.28 Range $2.62 - $4.56
Q2 2022
Shares 115,000 Value ($000) $362 Avg Close $2.74 Range $1.60 - $3.74
Q1 2022
Shares 115,000 Value ($000) $322 Avg Close $4.32 Range $2.74 - $5.60
Q4 2021
Shares 40,000 Value ($000) $180 Avg Close $7.22 Range $4.50 - $9.35